Literature DB >> 11420746

An N-terminal region of mot-2 binds to p53 in vitro.

S C Kaul1, R R Reddel, Y Mitsui, R Wadhwa.   

Abstract

The mouse mot-2 protein was earlier shown to bind to the tumor suppressor protein, p53. The mot-2 binding site of p53 was mapped to C-terminal amino acid residues 312-352, which includes the cytoplasmic sequestration domain. In the present study, we have found that both mot-1 and mot-2 bind to p53 in vitro. By using His-tagged deletion mutant proteins, the p53-binding domain of mot-2 was mapped to its N-terminal amino acid residues 253-282, which are identical in mot-1 and mot-2 proteins. Some peptides containing the p53-binding region of mot-2 were able to compete with the full-length protein for p53 binding. The data provided rationale for in vitro binding of mot-1 and mot-2 proteins to p53 and supported the conclusion that inability of mot-1 protein to bind p53 in vivo depends on secondary structure or its binding to other cellular factors. Most interestingly, the p53-binding region of mot-2 was common to its MKT-077, a cationic dye that exhibits antitumor activity, binding region. Therefore it is most likely that MKT-077-induced nuclear translocation and restoration of wild-type p53 function in transformed cells takes place by a competitional mechanism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420746      PMCID: PMC1505414          DOI: 10.1038/sj.neo.7900139

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  31 in total

Review 1.  Mechanisms of protein translocation into mitochondria.

Authors:  W Voos; H Martin; T Krimmer; N Pfanner
Journal:  Biochim Biophys Acta       Date:  1999-11-16

2.  Mitochondrial protein import motor: the ATPase domain of matrix Hsp70 is crucial for binding to Tim44, while the peptide binding domain and the carboxy-terminal segment play a stimulatory role.

Authors:  T Krimmer; J Rassow; W H Kunau; W Voos; N Pfanner
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

3.  Inactivation of p53 and life span extension of human diploid fibroblasts by mot-2.

Authors:  S C Kaula; R R Reddelb; T Sugiharac; Y Mitsuia; R Wadhwac
Journal:  FEBS Lett       Date:  2000-06-02       Impact factor: 4.124

4.  Attenuation of the induced differentiation of HL-60 leukemia cells by mitochondrial chaperone HSP70.

Authors:  J Xu; H H Xiao; A C Sartorelli
Journal:  Oncol Res       Date:  1999       Impact factor: 5.574

5.  Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function.

Authors:  R Wadhwa; T Sugihara; A Yoshida; H Nomura; R R Reddel; R Simpson; H Maruta; S C Kaul
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

6.  Structurally and functionally distinct mouse hsp70 family members Mot-1 and Mot-2 proteins are encoded by two alleles.

Authors:  S C Kaul; E Duncan; T Sugihara; R R Reddel; Y Mitsui; R Wadhwa
Journal:  DNA Res       Date:  2000-06-30       Impact factor: 4.458

7.  Transcriptional inactivation of p53 by deletions and single amino acid changes in mouse mot-1 protein.

Authors:  S C Kaul; S Takano; R R Reddel; Y Mitsui; R Wadhwa
Journal:  Biochem Biophys Res Commun       Date:  2000-12-20       Impact factor: 3.575

8.  Extramitochondrial localization of mortalin/mthsp70/PBP74/GRP75.

Authors:  Q Ran; R Wadhwa; R Kawai; S C Kaul; R N Sifers; R J Bick; J R Smith; O M Pereira-Smith
Journal:  Biochem Biophys Res Commun       Date:  2000-08-18       Impact factor: 3.575

9.  Induction of mitochondrial stress proteins following treadmill running.

Authors:  J P Mattson; C R Ross; J L Kilgore; T I Musch
Journal:  Med Sci Sports Exerc       Date:  2000-02       Impact factor: 5.411

10.  Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member.

Authors:  R Wadhwa; S Takano; M Robert; A Yoshida; H Nomura; R R Reddel; Y Mitsui; S C Kaul
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

View more
  19 in total

Review 1.  An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?

Authors:  Renu Wadhwa; Kazunari Taira; Sunil C Kaul
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

2.  Crystal structure of the nucleotide-binding domain of mortalin, the mitochondrial Hsp70 chaperone.

Authors:  Joseph Amick; Simon E Schlanger; Christine Wachnowsky; Mitchell A Moseng; Corey C Emerson; Michelle Dare; Wen-I Luo; Sujay S Ithychanda; Jay C Nix; J A Cowan; Richard C Page; Saurav Misra
Journal:  Protein Sci       Date:  2014-04-17       Impact factor: 6.725

3.  Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73.

Authors:  Hiroshi Katayama; Jin Wang; Warapen Treekitkarnmongkol; Hidehiko Kawai; Kaori Sasai; Hui Zhang; Hua Wang; Henry P Adams; Shoulei Jiang; Sandip N Chakraborty; Fumio Suzuki; Ralph B Arlinghaus; Jinsong Liu; James A Mobley; William E Grizzle; Huamin Wang; Subrata Sen
Journal:  Cancer Cell       Date:  2012-02-14       Impact factor: 31.743

4.  Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice.

Authors:  Tim H-P Chen; Amal Kambal; Kilannin Krysiak; Mark A Walshauser; Gagan Raju; Justin F Tibbitts; Matthew J Walter
Journal:  Blood       Date:  2010-12-01       Impact factor: 22.113

5.  Reduced levels of Hspa9 attenuate Stat5 activation in mouse B cells.

Authors:  Kilannin Krysiak; Justin F Tibbitts; Jin Shao; Tuoen Liu; Matthew Ndonwi; Matthew J Walter
Journal:  Exp Hematol       Date:  2014-12-27       Impact factor: 3.084

6.  Cloning, characterization, and functional studies of a human 40-kDa catecholamine-regulated protein: implications in central nervous system disorders.

Authors:  Joseph Gabriele; Giuseppe F Pontoriero; Nancy Thomas; Christy A Thomson; Kevin Skoblenick; Zdenek B Pristupa; Ram K Mishra
Journal:  Cell Stress Chaperones       Date:  2009-03-12       Impact factor: 3.667

7.  Targeting mortalin using conventional and RNA-helicase-coupled hammerhead ribozymes.

Authors:  Renu Wadhwa; Hiroshi Ando; Hiroaki Kawasaki; Kazunari Taira; Sunil C Kaul
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

Review 8.  Pharmacological targeting of the Hsp70 chaperone.

Authors:  Srikanth Patury; Yoshinari Miyata; Jason E Gestwicki
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

9.  Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy.

Authors:  Sanam Sane; Ammara Abdullah; Morgan E Nelson; Hongmin Wang; Subhash C Chauhan; Samuel S Newton; Khosrow Rezvani
Journal:  Cell Stress Chaperones       Date:  2015-12-04       Impact factor: 3.667

10.  Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences.

Authors:  Kirti Vaishnavi; Nishant Saxena; Navjot Shah; Rumani Singh; Kavyashree Manjunath; M Uthayakumar; Shankar P Kanaujia; Sunil C Kaul; Kanagaraj Sekar; Renu Wadhwa
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.